![]() |
인쇄하기
취소
|
121 products including ‘Ganilever Prefilled Syringe Inj’ which prevents premature luteinizatio will take an advantage, of the health insurance benefits as being registered for the national health insurance service.
‘Tecentriq Inj,’ a cancer immunotherapy, will be applied for the national health insurance service from 12 January under the upper limit system of risk sharing.
The Ministry of Hea...